Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Hausberg

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Blood Advances|July 8, 2020
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTPLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Blood Advances|July 8, 2020
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Blood Advances|July 8, 2020
ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTPLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Blood Advances|July 8, 2020
Real-world data confirm the effectiveness of caplacizumab in acquired thrombotic thrombocytopenic purpuraLinus A Völker, Jessica Kaufeld, Wolfgang Miesbach, et al.
Pageof 8